Bilirubin Nanomedicines for the Treatment of Reactive Oxygen Mediated Diseases

Reactive oxygen species (ROS) are important in causing many diseases, such as certain cancers, heart problems, and brain-related conditions. When there is too much ROS, it causes oxidative stress, which can damage cells and lead to disease. Bilirubin, which is a natural byproduct of breaking down heme, has strong antioxidant properties, making it a good option for treating these conditions. Bilirubin plays a major role in various diseases, including heart issues, brain disorders, and inflammation. Because of its strong antioxidant abilities, bilirubin is a promising treatment, and recent developments in nanotechnology have made it easier to deliver and use bilirubin effectively for diseases related to ROS. This abstract looks into the potential of bilirubin-based nanomedicine in preventing damage caused by ROS. When bilirubin is placed inside nanocarriers, it becomes more stable, easier for the body to use, and can be targeted specifically to the affected tissues. Bilirubin is a naturally occurring antioxidant that is made when heme breaks down and has shown great promise in reducing the harmful effects of ROS. The development of nanomedicine has become a promising approach to improve treatment effectiveness and allow for more targeted drug delivery. This review explores the use of bilirubin nanomedicine as a new treatment for disorders caused by ROS. The article discusses various biocompatible nanoparticles, like polymeric nanoparticles and liposomes. Bilirubin has been enclosed in lipid nanoparticles to improve its ability to work in the body and to keep it stable. Additionally, ligands can be used to specifically deliver bilirubin to nanoparticles through surface changes. These nanoparticles can then target the cells or tissues affected by oxidative stress. By attaching bilirubin to nanoparticles, its stability, how well it is taken up by cells, and how it is released in response to ROS or other signals are all improved.